微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 7.08% | -21.42% | 102.29% | 42/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.5% | 95.53% | 209.73% | 55/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.13% | -47.93% | -64.13% | 77/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.15% | -58.22% | -65.04% | 74/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 9.01% | 73.27% | 403.35% | 32/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.79% | -1.1% | -17.51% | 89/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.17% | 171.25% | -71.22% | 54/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 7.54% | 130.58% | 45% | 42/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.2% | 42.08% | 187.29% | 66/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.81% | 3.43% | 126.25% | 86/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.8% | -13.04% | -75.54% | 97/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 3.27% | 161.6% | -10.66% | 87/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.66% | -62.5% | 109.14% | 75/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.75% | 94.44% | 90.22% | 93/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.92% | -90.24% | -26.4% | 94/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.25% | -77.52% | -87.19% | 104/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 9.76% | -38.27% | 984.44% | 33/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.9% | -81.17% | -90.46% | 110/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 9.43% | 78.94% | 69.6% | 3/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 5.56% | -53.2% | -64.83% | 79/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 15.81% | -12.22% | 230.75% | 14/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.78% | -7.36% | -9.3% | 57/158 | 4.23% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 5.27% | 116.87% | -55.64% | 9/158 | 2.2% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.88% | 83.33% | -34.04% | 43/158 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 18.01% | 23.02% | 249.03% | 7/158 | 7.53% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.16% | 100.78% | 112.35% | 45/158 | 5% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.43% | -18.18% | -62.5% | 45/158 | 2.43% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.48% | 39.35% | -55.74% | 72/158 | 7.17% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 14.64% | 57.42% | 469.65% | 11/158 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.57% | -41.06% | -13.47% | 75/158 | 4.64% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.97% | 56.32% | -36.13% | 30/158 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.65% | -59.71% | -50% | 88/158 | 9.68% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.3% | -38.04% | 113.3% | 35/158 | 8.34% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.36% | -32.3% | 129.47% | 54/158 | 5.62% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.9% | -6.4% | -83.54% | 45/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.54% | -17.22% | -23.12% | 45/158 | 6.22% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 15.01% | 16.27% | 133.07% | 12/158 | 5.64% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 6.44% | -21.46% | 217.24% | 30/158 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.03% | -55.97% | -85.44% | 39/158 | 2.69% | 贝达药业 | 16.78% | 行业排名> |